Quercetin induces apoptosis in meningioma cells through the miR-197/IGFBP5 cascade

Shun-An Hu1, Jin Cheng2, Wo-Hua Zhao1

  • 1Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 4430022, China.

Insights

Quercetin, a natural compound, effectively reduces meningioma cell growth and promotes apoptosis. It achieves this by modulating the miR-197/IGFBP5 pathway and regulating key proteins involved in cell death.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Meningioma is a primary brain tumor with limited effective treatments.
  • Understanding the molecular mechanisms underlying meningioma growth is crucial for developing novel therapies.
  • Natural compounds like quercetin show potential in cancer treatment.

Purpose of the Study:

  • To investigate the anti-cancer effects of quercetin on meningioma cells.
  • To elucidate the molecular mechanisms, including apoptosis and gene expression changes, involved in quercetin's action.
  • To explore the role of the miR-197/IGFBP5 pathway in quercetin-treated meningioma cells.

Main Methods:

  • HBL-52 meningioma cells were treated with varying doses and time points of quercetin.
  • Cell viability was assessed using the Cell Counting kit-8 (CCK-8) assay.
  • Apoptosis, protein expression (Bax, Bcl-2, IGFBP5), and mRNA levels (IGFBP5, miR-197) were analyzed using flow cytometry, western blot, and qRT-PCR, respectively.
  • The interaction between miR-197 and IGFBP5 was confirmed via a dual luciferase assay.

Main Results:

  • Quercetin demonstrated a dose- and time-dependent reduction in HBL-52 cell viability and proliferation.
  • Apoptosis was significantly increased in quercetin-treated cells.
  • Quercetin altered the expression of apoptosis-related proteins (decreased Bcl-2, increased Bax) and modulated gene expression (increased miR-197 mRNA, decreased IGFBP5 mRNA).
  • The dual luciferase assay confirmed a direct interaction between miR-197 and IGFBP5, with miR-197 overexpression leading to reduced IGFBP5 expression.

Conclusions:

  • Quercetin exhibits significant anti-proliferative and pro-apoptotic effects on meningioma cells.
  • The miR-197/IGFBP5 signaling pathway is a key mediator of quercetin's anti-cancer activity in meningioma.
  • Quercetin's therapeutic potential in meningioma may involve the regulation of the miR-197/IGFBP5 cascade and the Bcl-2/Bax balance.